Perrigo | PRGO - Операционные расходы





Операционные расходы Изменить Дата
AbbVie USD 10.27B 538M 2026-03
Abbott USD 9.31B 104M 2026-03
Bayer EUR 10.33B 126M 2025-12
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Coherus Biosciences USD 51.83M 2.48M 2025-12
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Dr.Reddys Laboratories INR 73.6B 1.79B 2025-12
Eli Lilly USD 10.02B 285M 2026-03
J&J USD 17.44B 1.53B 2026-03
Merck USD 18.17B 8.01B 2026-03
Nestle CHF 38.42B 1.33B 2025-12
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 1.03B 75.3M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Reckitt Benckiser GBP 6.26B 3.51B 2024-12
Sanofi EUR 9.31B 1.2B 2026-03
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Teva Pharmaceutical Industries USD 3.22B 1000M 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zoetis USD 1.55B 3.85B 2025-12